Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-long FOV PET/CT for Indeterminate Lung Nodules
NCT05463913Phase 4Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2022
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by University Medical Center Groningen. Primary endpoints: Description of optimized static whole-body acquisition and reconstruction protocol up to 2 years, Description of optimized dynamic whole-body acquisition and reconstruction protocol up to 2 years and 1 more. Started Jul 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05463913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05463913.